Physicochemical Properties
| Molecular Formula | C9H11FN2O5 | 
| Molecular Weight | 246.19 | 
| Exact Mass | 246.065 | 
| CAS # | 784-71-4 | 
| Related CAS # | 2'-Deoxy-2'-fluorouridine-d2;362049-50-1 | 
| PubChem CID | 150851 | 
| Appearance | White to off-white solid powder | 
| Density | 1.6±0.1 g/cm3 | 
| Melting Point | 151 °C | 
| Index of Refraction | 1.608 | 
| LogP | -1.31 | 
| Hydrogen Bond Donor Count | 3 | 
| Hydrogen Bond Acceptor Count | 6 | 
| Rotatable Bond Count | 2 | 
| Heavy Atom Count | 17 | 
| Complexity | 374 | 
| Defined Atom Stereocenter Count | 4 | 
| SMILES | C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)F | 
| InChi Key | UIYWFOZZIZEEKJ-XVFCMESISA-N | 
| InChi Code | InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1 | 
| Chemical Name | 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | 
| HS Tariff Code | 2934.99.9001 | 
| Storage | Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month | 
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) | 
Biological Activity
| References | [1]. Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents. J Med Chem. | 
Solubility Data
| Solubility (In Vitro) | DMSO : 100 mg/mL (406.19 mM) | 
| Solubility (In Vivo) | Solubility in Formulation 1:  ≥ 2.5 mg/mL (10.15 mM) (saturation unknown)  in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (10.15 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (10.15 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) | 
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.0619 mL | 20.3095 mL | 40.6190 mL | |
| 5 mM | 0.8124 mL | 4.0619 mL | 8.1238 mL | |
| 10 mM | 0.4062 mL | 2.0310 mL | 4.0619 mL | 
